Cargando…

Increasing SARS-CoV-2 Vaccine Counseling by Fellows in the Allergy Clinic

Detalles Bibliográficos
Autores principales:	Kahwash, Basil, Corey, Kristen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804437/ http://dx.doi.org/10.1016/j.jaci.2021.12.172

Ejemplares similares

Allergy/Immunology Trainee Experiences During the COVID-19 Pandemic: AAAAI Work Group Report of the Fellows-in-Training Committee
por: Kahwash, Basil M., et al.
Publicado: (2021)

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next
por: Corey, Kristen B., et al.
Publicado: (2022)

Safety of Inactivated SARS-CoV-2 Vaccines Among Adults with Experience of Allergies to Food or Medicines
por: Jin, Yan, et al.
Publicado: (2023)

Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2
por: Restivo, Vincenzo, et al.
Publicado: (2021)

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
por: Lewnard, Joseph A., et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Written Briefing and Oral Counseling Increase the Willingness to Receive the SARS-CoV-2 Vaccination among Women in Puerperium: A Qualitative Prospective Cohort Study
por: Schirwani, Nawa, et al.
Publicado: (2022)

Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()
por: Paoletti, Giovanni, et al.
Publicado: (2021)

Is SARS-CoV-2 Vaccination of Subjects with a Prior History of Allergies Dangerous? Experiences in the Veneto Region of Italy
por: Cocchio, Silvia, et al.
Publicado: (2023)

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees
por: Asperti, Chiara, et al.
Publicado: (2022)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
por: Jackson, Daniel J., et al.
Publicado: (2020)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

SARS-CoV-2 Vaccines and the Skin()
por: Galván-Casas, C., et al.
Publicado: (2021)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

SARS-CoV-2 vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2023)

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
por: Swan, David A., et al.
Publicado: (2021)

The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience
por: Rush, Cassandra, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center
por: Tanno, Luciana Kase, et al.
Publicado: (2021)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
por: Basheeruddin Asdaq, Syed Mohammed, et al.
Publicado: (2022)

Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients
por: Torres, Rubén, et al.
Publicado: (2022)

Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma?
por: Hajighasemi, Saeideh, et al.
Publicado: (2023)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
por: Yue, Can, et al.
Publicado: (2023)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
por: Malli, Foteini, et al.
Publicado: (2022)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
por: Souza, William M, et al.
Publicado: (2021)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1pht2oiqec69pgvjdn3ji6ocf2